World Library  
Flag as Inappropriate
Email this Article

17-beta-hydroxysteroid Dehydrogenase Deficiency

 

17-beta-hydroxysteroid Dehydrogenase Deficiency

17β-Hydroxysteroid dehydrogenase deficiency
Classification and external resources
OMIM 264300
DiseasesDB 32638

17β-Hydroxysteroid dehydrogenase III deficiency is a rare disorder of sexual development affecting testosterone biosynthesis by 17β-hydroxysteroid dehydrogenase III (17β-HSD III), which can produce impaired virilization (traditionally termed male pseudohermaphroditism) of genetically male infants and children and excessive virilization of female adults.

It is an autosomal recessive[1] condition and is one of the few disorders of sexual development that can affect the primary and/or secondary sex characteristics of both males and females.

Contents

  • Prevalence 1
  • Clinical characteristics 2
  • Biochemistry 3
  • Genetics 4
  • See also 5
  • References 6
  • External links 7

Prevalence

In the Netherlands, 17β-hydroxysteroid dehydrogenase III deficiency is estimated to occur in 1:147,000 newborns.[2]

Clinical characteristics

17-β-Hydroxysteroid dehydrogenase III deficiency is clinically characterized by either ambiguous external genitalia or complete female external genitalia at birth; as a consequence of impaired male sexual differentiation in 46,XY individuals. Further investigations on ambiguous genitalia will eventually lead to findings of intersexuality. Severely impaired virilization (often complete absence of male sexual differentiation) can lead to development of female external genitalia. These children are raised as female, and their diagnosis is often discovered when there is absence of menarche (first menstruation) and when they begin to virilize during puberty (slowly become more like a man; deepening of the voice, acne, male musculature etc.). At careful examination, testis can often be found in the inguinal channel.

Biochemistry

Biochemical effects of 17β-hydroxysteroid deficiency-3 in testosterone biosynthesis. Typically levels of androstenedione are significantly increased, whilst testosterone levels are decreased, leading to male undervirilization.

17β-Hydroxysteroid dehydrogenase III deficiency is characterized biochemically by decreased levels of testosterone and increased levels of androstenedione as a result of the defect in conversion of androstenedione into testosterone. This leads to clinically important higher ratio of androstenedione to testosterone (A'dion/T) (see figure).

Genetics

17β-hydroxysteroid dehydrogenase deficiency has an autosomal recessive pattern of inheritance.

17β-Hydroxysteroid dehydrogenase III deficiency is caused by mutations found in the 17β-HSD III (17BHSD3) gene.[3] 17β-HSD III deficiency is an autosomal recessive disorder.

See also

References

  1. ^ Andersson, S; Geissler, Wm; Wu, L; Davis, Dl; Grumbach, Mm; New, Mi; Schwarz, Hp; Blethen, Sl; Mendonca, Bb; Bloise, W; Witchel, Sf; Cutler, Gb, Jr; Griffin, Je; Wilson, Jd; Russel, Dw (January 1996). "Molecular genetics and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 deficiency". The Journal of Clinical Endocrinology and Metabolism 81 (1): 130–6.  
  2. ^ Boehmer, A. L. M. (1999). "17 -Hydroxysteroid Dehydrogenase-3 Deficiency: Diagnosis, Phenotypic Variability, Population Genetics, and Worldwide Distribution of Ancient and de Novo Mutations". Journal of Clinical Endocrinology & Metabolism 84 (12): 4713–21.  
  3. ^ Lindqvist, A; Hughes, Ia; Andersson, S (February 2001). "Substitution mutation C268Y causes 17 beta-hydroxysteroid dehydrogenase 3 deficiency" (Free full text). The Journal of Clinical Endocrinology and Metabolism 86 (2): 921–3.  

External links

This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.